Open-Label Study of 18F-mFBG for Imaging Myocardial Sympathetic Innervation

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 5, 2021

Primary Completion Date

March 7, 2025

Study Completion Date

March 7, 2025

Conditions

Cardiovascular Diseases

Interventions

DRUG

18F-mFBG for intravenous administration

Positron-emitting tomography (PET) (either PET/CT or PET/MR) imaging agent

Trial Locations (1)

Mount Sinai Morningside, New York

All Listed Sponsors

collaborator

Mount Sinai Hospital, New York

OTHER

lead

Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)

INDUSTRY

NCT04535193 - Open-Label Study of 18F-mFBG for Imaging Myocardial Sympathetic Innervation | Biotech Hunter | Biotech Hunter